Approaching Complementary and Alternative Medicine Use in Patients with Cancer: Questions and Challenges

Journal of Ambulatory Care Management

Volumn 27, Issue 1, 2004, Pages 53-62

  Ben Arye, Eran ^a,b,c,d   Frenkel, Moshe ^a   Margalit, Ruth Stashefsky ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CAM Education Project   (Israel)

^c Klalit Health Services   (Israel)

^d Haifa and Western Galilee District ^*  (Israel)

Author keywords

Cancer; Complementary alternative medicine (CAM); Evidence based medicine; Patient doctor relationship; Primary care; Randomized controlled trials

Indexed keywords

BELLADONNA ALKALOID; BETA CAROTENE; FLUOROURACIL; FOLIC ACID; MITOMYCIN C; SELENIUM; VISCUM ALBUM EXTRACT; XIAO CHAI HU TANG; ZINC SULFATE;

ACUPUNCTURE; ALTERNATIVE MEDICINE; CANCER PATIENT; CANCER THERAPY; COGNITIVE THERAPY; DOCTOR PATIENT RELATION; HEALTH CARE QUALITY; HOMEOPATHY; HUMAN; HYPNOSIS; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; REVIEW; SUPPORT GROUP;

EID: 0347594040     PISSN: 01489917     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004479-200401000-00007     Document Type: Review

References (79)

1. Alferi, S. M., Antoni, M. H., Ironson, G., Kilbourn, K. M., & Carver, C. S. (2001). Factors predicting the use of complementary therapies in a multi-ethnic sample of early-stage breast cancer patients. Journal of American Medical Womens Association, 56(3), 120-123, 126.
2. Andersen, L., Hojris, I., Erlandsen, M., & Andersen, J. (2000). Treatment of breast-cancer-related lymphedema with or without manual lymphatic drainage - A randomized study. Acta Oncologica, 39(3), 399-405.
3. Antman, K., Benson, M. C., Chabot, J., Cobrinik, D., Grann, V. R., Jacobson, J. S., et al. (2001). Complementary and alternative medicine: The role of the cancer center. Journal of Clinical Oncology, 19(18S), 55S-60S.
4. Association of American Medical Colleges. (1999, October). Contemporary issues in medicine: Communication in medicine (Medical School objectives project, Report III). Washington, DC: Author.
5. Balzarini, A., Felisi, E., Martini, A., & De Conno, F. (2000). Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: A randomized, double-blind clinical trial. British Homeopathic Journal, 89(1), 8-12.
6. Blom, M., Dawidson, I., Frenberg, J. O., & Angmar-Mannson. (1996). Acupuncture treatment of patients with radiation-induced xerostomia. Oral Oncology, European Journal of Cancer, 32B(3), 182-190.
7. Boon, H., Stewart, M., Kennard, M. A., Gray, R., Sawka, C., Brown, J. B., et al. (2000). Use of complementary/alternative medicine by breast cancer survivors in Ontario: Prevalence and perceptions. Journal of Clinical Oncology, 18(13), 2515-2521.
8. Bourgeault, I. L. (1996). Physicians' attitudes towards patients' use of alternative cancer therapies. Canadian Medical Association Journal, 155(12), 1679-1685.
9. Buiatti, E., Arniani, S., Verdecchia, A., Tomatis, L., and the Italian Cancer registries. (1999). Results from a historical survey of the survival of cancer patients given Di Bella multitherapy. Cancer, 86, 2143-2149.
10. Burstein, H. J. (2000). Discussing complementary therapies with cancer patients: What should we be talking about? Journal of Clinical Oncology, 18(13), 2501-2504.
11. California Department of Health Services. (2002, February 7). State health director warns consumers about prescription drugs in herbal products. Available at: http://www.applications.dhs.ca.gov/pressreleases/ store/pressreleases/02-03.html
12. Cassileth, B. R. (1999). Alternative and complementary medicine. Separating the wheat from the chaff. Cancer, 86(10), 1900-1902.
13. Childers, J. M., Chu, J., Voigt, L. E, Feigi, P, Tamimi, H. K., Franklin, E. W., et al. (1995). Chemoprevention of cervical cancer with folic acid: A phase III Southwest Oncology Group Intergroup study. Cancer Epidemiology, Biomarkers and Prevention, 4(2), 155-159.
14. Clark, L. C., Dalkin, B., Krongrad, A., Combs, G. F., Turnbull, B. W., Slate, E. H., et al. (1998). Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. British Journal of Urology, 81(5), 730-734.
15. Coss, R. A., McGrath, P., & Caggiano, V. (1998). Alternative care. Patient choices for adjunct therapies within a cancer center. Cancer Practice, 6(3), 176-181.
16. Crocetti, E., Crotti, N., Feltrin, A., Ponton, P., Geddes, M., & Buiatti, E. (1998). The use of complementary therapies by breast cancer patients attending conventional treatments. European Journal of Cancer, 34(3), 324-328.
17. Crocetti, E., Crotti, N., Montella, M., & Musso, M. (1996). Complementary medicine and oncologists' attitudes: A survey in Italy. Tumori, 82(6), 539-542.
18. Cunningham, A. J., Edmonds, C. V., Jenkins, J. P., Pollack, H., Lockwood, G. A., & Warr, D. (1998). A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer. Psychooncology, 7(6), 508-517.
19. Dossey, L. (2001). Being green: On the relationships between people and plants. Alternative Therapies in Health and Medicine, 7(3), 12-16, 132-140.
20. Downer, S. M., Cody, M. M., McCluskey, P., Wilson, P. D., Arnott, S. J., Lister, T. A., et al. (1994). Pursuit and practice of complementary therapies by cancer patients receiving conventional treatments. BMJ, 309, 86-89.
21. Edgar, L., Remmer, J., Rosberger, Z., & Fournier, M. A. (2000). Resource use in women completing treatment for breast cancer. Psychooncology, 9(5), 428-438.
22. Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., et al. (1998). Trends in alternative medical use in the Unites States, 1990-1997. JAMA, 280, 1569-1575.
23. Ernst, E., & Cassileth, B. R. (1998). The prevalence of complementary/alternative medicine in cancer. Cancer, 83(4), 777-782.
24. Ernst, E., & Cassileth, B. R. (1999). How useful are unconventional cancer treatments? European Journal of Cancer, 35(11), 1608-1613.
25. Fallowfield, L., & Jenkins, V. (1999). Effective coommunication skills are the key to good cancer care. European Journal of Cancer, 35(11), 1592-1597.
26. Fawzy, F. I. (1993). Malignant melanoma. Effects of an early structured psychiatric intervention, coping and affective state on recurrence and survival 6 years later. Archives of General of Psychiatry, 50, 681-689.
27. Fernandez, C. V., Stutzer, C. A., MacWilliam, L., & Fryer, C. (1998). Alternative and complementary use in pediatric oncology patients in British Columbia: Prevalence and reasons for use and nonuse. Journal of Clinical Oncology, 16(4), 1279-1286.
28. Frieling, U. M., Schaumberg, D. A., Kupper, T. S., Muntwyler, J., & Hennekens, C. H. (2000). A randomized 12-year primary supplementation for nonmelanoma skin cancer in the physician's health study. Archives of Dermatology, 136(2), 179-184.
29. Frenkel, M., & Ben-Arye, E. (2001). The growing need to teach about complementary and alternative medicine: Questions and challenges. Academic Medicine, 76, 251-254.
30. Gordon, J. S. (2000). Comprehensive cancer care (1st ed.). Perseus Publishing.
31. Gray, R. E., Fitch, M., & Greenberg, M. (1998). A comparison of physician and patient perspectives on unconventional cancer therapies. Psychooncology, 7(6), 445-452.
32. Grossarth-Maticek, R., Kiene, H., Baumgartner, S. M., & Ziegler, R. (2001). Use of Iscador, an extract of European mistletoe (Viscum album) in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Alternative Therapies in Health and Medicine, 7(3), 57-66, 68-72, 74-76.
33. Halperin, J. D., Zabora, J. R., & BrintzenhofeSzoc, K. (1997,July/August 20-22). The emotional health of oncologists. Oncology Issues, 12.
34. He, J. P., Friedrich, M., Ertan, A. K., Muller, K., & Schmidt, W. (1999). Pain-relief and movement improvement by acupuncture after ablation and axillary lymphadenectomy in patients with mammary cancer. Clinical and Experimental Obstetrics and Gynecology, 26(2), 81-84.
35. M. D. Anderson Cancer Center Complementary/Integrative Medicine Education Resources. Available at: http://www.sph.uth.tmc.edu/utcam/
36. Jacknow, D. S., Tschann, J. M., Link, M. P., & Boyce, W. T. (1994). Hypnosis in the prevention of chemotherpy-related nausea and vomiting in children: A prospective study. Journal of Development and Behavioral Pediatrics, 15(4), 258-264.
37. Joos, S. K., Hickman, D. H., Gordon, G. H., & Baker, L. H. (1995). Effects of a physician communication skills in medicine. Journal of General Internal Medicine, 11, 147-155.
38. Kao, G. D., Devine, P. (2000). Use of complementary health practices by prostate carcinoma patients undergoing radiation therapy. Cancer, 88(3), 615-619.
39. Kappauf, H., Leykauf-Ammon, D., Bruntsch, U., Horneber, M., Kaiser, G., Buschel, G., et al. (2000). Use of and attitudes held towards unconventional medicine by patients in a department of internal medicine/oncology and haematology. Support Care Cancer, 8(4), 314-322.
40. Kligler, B., Gordon, A., Stuart, M., & Sierpina V. (2000). Suggested curriculum guidelines on complementary medicine and alternative medicine: Recommendations of the Society of Teachers of Family Medicine Group on alternative medicine. Family Medicine, 32, 30-33.
41. Kurtz, S., Silverman, J., & Draper, J. (1998). Radcliffe Medical Press. Oxon, UK: Teaching and learning communication skills in medicine.
42. Levinson, W., Roter, D. L., Mullooly, J., Dull, V., & Frankel, R. M. (1997). Doctor-patient communication. A critical link to malpractice in surgeons and primary care physicians. JAMA, 277(7), 553-559.
43. Little, P, Everitt, H., Williamson, I., Warner, G., Moore, M., Gould, C., et al. (2001). Observational study of effect of patient centerdness and positive approach on outcomes of general practice consultations. BMJ, 323(7318), 908-911.
44. Liu, J. M., Chu, H. C., Chin, Y. H., Chen, Y. M., Hsieh, R. K., Chiou, T. J., et al. (1997). Cross sectional study of the use of alternative medicines in Chinese cancer patients. Japanese Journal of Clinical Oncology, 27(1), 37-41.
45. Maguire, P. (1999). Improving communication with cancer patients. European Journal of Cancer, 35(10), 1415-1422.
46. Makoul, G., & Schofield, T. (1999). Communication teaching and assessment in medical education: An international consensus statement. Patient Education Counseling, 37, 191-195.
47. Maskarinec, G., Shumay, D. M., Kakai, H., & Gotay, C. C. (2000). Ethnic differences in complementary and alternative medicine use among cancer patients. Journal of Alternative and Complementary Medicine, 6(6), 531-538.
48. Miller, M., Boyer, M. J., Butow, P. N., Gattellari, M., Dunn, S. M., & Childs, A. (1998). The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost. Support Care Cancer, 6(4), 337-347.
49. Mitomi, T., Tsuchiya, S., Iijima, N., Aso, K., Suzuki, K., Nishiyama, K., et al. (1992). Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The cooperative group of surgical adjuvant immunochemotherapy for cancer of colon and rectum (Kanagawa). Diseases of the Colon and Rectum, 35(2), 123-130.
50. Morant, R., Jungi, W. F., Koehli, C., & Senn, H. J. (1991). Why do cancer patients use alternative medicine? Schweizerishe Medizinische Wochenschritt, 121(27/ 28), 1029-1034.
51. Newell, S., & Sanson-Fisher, R. W. (2000). Australian oncologists' self-reported knowledge and attitudes about non-traditional therapies used by cancer patients. The Medical Journal of Australia, 172(3), 110-113.
52. Nunstedt, K., Entezami, A., Wartenberg, A., & Kullmer, U. (2000). The attitudes of physicians and oncologists towards unconventional cancer therpies(UCT). European Journal of Cancer, 36, 2090-2095.
53. Oberbaum, M., Yaniv, I., Ben-Gal, Y., Stein, J., Ben-Zvi, N., Freedman, L. S., et al. (2001). A randomized, controlled clinical trial of the homeopathic medication Traumeel S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer, 92(3), 684-690.
54. Oka, H., Yamamoto, S., Kuroki, T., Harihara, S., Marumo, T., Kim, S. R., et al. (1995). Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer, 76(5), 743-749.
55. Oneschuk, D., Fennell, L., Hanson, J., & Bruera, E. (1998). The use of complementary medications by cancer patients attending an outpatient pain and symptom clinic. Journal of Palliative Care, 14(4), 21-26.
56. Paltiel, O., Avitzour, M., Peretz, T., Cherny, N., Kaduri, L., Pfeffer, R. M., et al. (2001). Determinants of the use of complementary therapies by patient with cancer. Journal of Clinical Oncology, 19(9), 2439-2448.
57. Rees, R. W., Feigel, I., Vickers, A., Zollman, C., McGurk, R., & Smith, C. (2000). Prevalence of complementary therapy use by women with breast-cancer. A population-based survey. European Journal of Cancer, 36(11), 1359-1364.
58. Richardson, M. A., Post-White, J., Singletary, S. E., & Justice, B. (1998). Recruitment for complementary/alternative medicine trials: Who participates after breast cancer. Annals of Behavioral Medicine, 20(3), 190-198.
59. Richardson, M. A., Russell, N. C., Sanders, T., Barrett, R., & Salveson, C. (2001). Assessment of outcomes at alternative medicine cancer clinic: A feasibility study. Journal of Alternative and Complementary Medicine, 7(1), 19-31.
60. Richardson, M. A., Sanders, T., Palmer, L., Greisinger, A., & Singletary, E. (2000). Complementary/alternative medicine in a comprehensive cancer center and the implications for oncology. Journal of Clinical Oncology, 18(13), 2505-2514.
61. Ripamonti, C., Zecca, E., Brunelli, C., Fulfaro, F., Villa, S., Balzarini, A., et al. (1998). A randomized controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer, 82(10), 1938-1945.
62. Salmenpera, L., Suominen, T., Lauri, S., & Puuka, P. (2001). Attitudes of patients with breast and prostate cancer toward complementary therapies in Finland. Cancer Nursing, 24(4), 328-334.
63. Sapir, R., Catane, R., Kaufman, B., Isacson, R., Segal, A., Wein, S., et al. (2000, November). Cancer patient expectations of and communication with oncologists and oncology nurses: The experience of an integrated oncology and palliative care service. Supportive Care in Cancer, 8(6), 458-463.
64. Shen, J., Wenger, N., Glaspy, J., Hays, R. D., Albert, P. S., Choi, C., et al. (2000). Electroacupuncture for control of myeloablative chemotherapy-induced nausea: A randomized controlled trial. JAMA, 284(21), 2755-2761.
65. Simpson, M., Buckman, R., Stewart, M., Maguire, P., Lipkin, M., Novack, D., et al. (1991). Doctor-patient communication: The Toronto Cosensus statement. BMJ, 303(6814), 1385-1387.
66. Small, E. J., Frohlich, M. W., Bok, R., Shinohara, K., Grossfeld, G., Rozenblat, Z., et al. (2000). Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. Journal of Clinical Oncology, 18(21), 3595-3603.
67. Sollner, W., Maislinger, S., DeVries, A., Steixner, E., Rumpold, G., & Lukas, P. (2000). Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but active coping behavior: A survey. Cancer, 89(4), 873-880.
68. Sparber, A., Bauer, L., Curt, G., Eisenberg, D., Levin, T., Parks, S., et al. (2000). Use of complementary medicine by adult patients participating in cancer clinical trials. Oncology Nursing Forum, 27(4), 623-630.
69. Spiegel, D., Bloom, J. R., Kraemer, H. C., & Gottheil, E. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2(8668), 888-891.
70. Stevensen, C. (1996). Assessing needs of people with cancer. Contemporary Nurse, 5(1), 36-39.
71. Stewart, M., Brown, J. B., Boon, H., Galajda, J., Meredith, L., & Sangster, M. (1999). Evidence on patient-doctor communication. Cancer Prevention and Control, 3(1), 25-30.
72. Talik-Koo, Yun., & Shoo-Yong, Choi. (1998). Non-organ specific cancer prevention of ginseng: A prospective study in Korea. International Journal of Epidemiology, 27, 359-364.
73. Troesch, L. M., Rodenhaver, C. B., Delaney, E. A., & Yanes, B. (1993). The influence of guided imagery on chemotherapy-related nausea and vomiting. Oncology Nursing Forum, 20(8), 1179-1185.
74. U.S. Office of Technology Assessment. (1990). Unconventional cancer treatments. Washington, DC: Author.
75. Verhoef, M. J., White, M. A., & Doll, R. (1999). Cancer patients' expectations of the role of family physicians in communication about complementary therapies. Cancer Prevention and Control, 3(3), 181-187.
76. Walker, L. G., & Anderson, J. (1999). Testing complementary and alternative therapies within a research protocol. European Journal of Cancer, 35(11), 1614-1618.
77. Walker, L. G., Walker, M. B., Ogston, K., Heys, S. D., Ah-See, A. K., Miller, I. D., et al. (1999). Psychological, clinical and pathological effects of relaxation training and guided imagery during primary chemotherapy. British Journal of Cancer, 80(1/2), 262-268.
78. Wetzel, M., Kaptchuk, T. J., Haramati, A., & Eisenberg, D. M. (2003). Complementary and alternative therapies: Implications for medical education. Annals of Internal Medicine, 138, 191-196.
79. Wyatt, G. K., Friedman, L. L., Given, C. W., Given, B. A., & Beckrow, K. C. (1999). Complementary therapy use among older cancer therapy. Cancer Practice, 7(3), 136-144.